$NUVB News

Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026

Citigroup Initiates Coverage of Nuvation Bio with Buy

Citigroup Initiates Coverage On Nuvation Bio with Buy Rating, Announces Price Target of $12

Why Is Nuvation Bio Stock Gaining Thursday?

Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer

Nuvation Bio Says FDA Approves sNDA For IBTROZI, ROS1 Inhibitor For Treatment Of Locally Advanced Or Metastatic ROS1-Positive Non-Small Cell Lung Cancer

Nuvation Bio (NUVB) Reports IBTROZI Efficacy Across ROS1 Lung Cancer Subgroups

Citizens Reiterates Market Outperform on Nuvation Bio, Maintains $10 Price Target

Wedbush Reiterates Outperform on Nuvation Bio, Maintains $11 Price Target

Nuvation Bio Inc. (NUVB) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI® (taletrectinib) Across Key Patient Subgroups in Advanced ROS1+ NSCLC at 2026 World Conference on Lung Cancer

Nuvation Bio Announces New Subgroup Analyses From Pivotal TRUST-I And TRUST-II Studies Evaluating IBTROZI In Both TKI- Naïve And TKI-Pretreated Patients With Advanced ROS1+ NSCLC

Nuvation Bio Inc. (NUVB) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Does Nuvation Bio (NUVB) Have the Potential to Rally 91.92% as Wall Street Analysts Expect?

Nuvation Bio to Participate in Upcoming Investor Conferences

Nuvation Bio (NUVB) Upgraded to Buy: Here's Why

Nuvation: Why I'm Downgrading To Hold Despite Progress On NSCLC And Glioma Fronts

Cantor Fitzgerald Initiates Coverage of Nuvation Bio (NUVB) with Overweight Recommendation

Cantor Fitzgerald Initiates Coverage On Nuvation Bio with Overweight Rating

Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma